Purple Biotech Ltd.
PPBT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $13 | $32 | $35 | $12,127 |
| - Cash | $9,592 | $4,736 | $5,772 | $7,401 |
| + Debt | $256 | $103 | $137 | $183 |
| Enterprise Value | -$9,323 | -$4,601 | -$5,600 | $4,909 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$58 | -$48 | -$45 | -$40 |
| % Margin | – | – | – | – |
| EBITDA | -$1,248 | -$1,042 | -$376 | -$886 |
| % Margin | – | – | – | – |
| Net Income | -$1,309 | -$1,085 | -$453 | -$410 |
| % Margin | – | – | – | – |
| EPS Diluted | -58 | -80 | -34 | -0.2 |
| % Growth | 27.5% | -135.3% | -16,900% | – |
| Operating Cash Flow | -$1,009 | -$1,544 | -$1,978 | -$2,014 |
| Capital Expenditures | $1,009 | -$2 | $0 | $0 |
| Free Cash Flow | $0 | -$1,546 | -$1,978 | -$2,014 |